Official Title
Prevalence of COVID-19 and Risk Factors Associated With Seroconversion in La Rinconada, the Highest City of the World - 5,100 m
Brief Summary

Since the beginning of 2020, SARS-CoV-2 outbreak spread over the world, conducting in a pandemic state declared by the world health organization in March 2020. Conflicting data have been yet published regarding to the incidence rate of COVID-19 infection in altitude. Mainly based on analysis from national Peru database, some authors argued that COVID-19 disease, as well as case fatality rate was less frequent in altitude. However, epidemiological data are lacking regarding to the prevalence of COVID-19 in altitude, and more specially in high altitude. Aim of this cross-sectional study is to assess the prevalence of seroconversion for the SARS-CoV-2 in the population of La Rinconada, a mining town at 5,100 m, the highest city in the world.

Unknown status
COVID19
High Altitude

Diagnostic Test: SARS-CoV-2 rapid diagnostic test (COVID-PRESTO® IgM/IgG, AAZ, Boulogne-Billancourt, France)

Presence of specific SARS-CoV-2 antibodies (IgM or IgG).

Eligibility Criteria

Inclusion Criteria:

- Age > 18 years.

Exclusion Criteria:

- Age < 18 years.

- Inability to give informed consent.

Eligibility Gender
All
Eligibility Age
Minimum: 18 Years ~ Maximum: N/A
Countries
Peru
Locations

La Rinconada
Puno, Peru

Centre d'Expertise sur l'Altitude EXALT
NCT Number
Keywords
Prevalence
Covid-19
SARS-CoV-2
Hight altitude
MeSH Terms
COVID-19